MS SC505

Encourages making hydroxychloroquine available in Mississippi for treating COVID-19, both as a preventive measure and as immediate therapy after confirmed or suspected exposure

Supports physicians prescribing hydroxychloroquine to patients who provide informed consent about the treatment regimen

Cites a July 2020 Henry Ford Health System study claiming hydroxychloroquine reduced COVID-19 mortality by 50 percent

References Yale epidemiology professor Harvey Risch's statement that 75,000 to 100,000 lives could be saved if hydroxychloroquine stockpiles were released

Directs copies of the resolution be sent to the Mississippi Department of Health for distribution to constituents